by Saliva collection devices are medical devices that enable collection and transportation of saliva samples for diagnosis of various infectious and lifestyle diseases. These devices offer benefits such as non-invasive collection method, minimal risk of infection transmission in comparison to blood samples, and easy sampling process. Rapid detection of diseases like cancers, cardiac disorders, HIV and others using saliva samples is driving the adoption of saliva collection devices. The global Saliva Collection Devices Market is estimated to be valued at US$ 297.27 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological advancements in saliva-based diagnostics is one of the major trends fueling the growth of saliva collection devices market. Companies are focusing on development of novel saliva collection kits integrated with diagnostic platforms for rapid detection of biomarkers. For instance, Salimetrics has introduced SalivaBio Children’s Swab and Storage Kit that allows collection of small saliva samples from infants and young children with ease. Similarly, companies are incorporating innovations like biosensors and microfluidics in saliva collection to enable quantifiable, reproducible and automated detection procedures at point-of-care settings. This is anticipated to boost adoption of saliva collection devices during the forecast period.
SWOT Analysis
Strength: Saliva collection devices offer non-invasive and pain-free sample collection methods. This drives higher patient acceptance and compliance.
Weakness: Storage and transportation of saliva samples pose challenges due to contamination risks. Limited capabilities in detecting certain diseases effectively from saliva.
Opportunity: Rising demand for alternative biosampling methods and increasing focus on preventive healthcare are driving growth opportunities. Growing applications in diagnostics of infectious diseases, genetic/molecular testing will boost demand.
Threats: Stringent regulatory framework and quality standards pose compliance challenges. Reimbursement issues restrict market growth in some regions.
Key Takeaways
The Global Saliva Collection Devices Market Size is expected to witness high growth.
Regional analysis: The North America region currently dominates the market and is expected to maintain its leading position during the forecast period. Higher adoption of advanced diagnostic technologies, increasing prevalence of chronic and infectious diseases are driving the market in the region. Asia Pacific is anticipated to be the fastest growing market owing to rising healthcare expenditure, increasing patient awareness levels.
Key players operating in the saliva collection devices market are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG. These companies focuses on new product launches, strategic collaborations and partnerships to gain market share and strengthen their product portfolio. For instance, in February 2022, Quest Diagnostics launched a new saliva collection kit for COVID-19 PCR testing.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
